A disruptive player in the orthodontics market competes against a newer disruptor that's now publicly traded. Should Align shareholders be worried?
News & Analysis: Align Technology
Investors continue to worry about decelerating growth at the orthodontic-device specialist.
The company behind Invisalign tempered its expectations for growth in its Asia-Pacific segment.
These medical device stocks appear to have what it takes to be long-term winners.
These three companies showcase why being debt-free can be great for business.
Earnings season led to some casualties among hard-hit stocks.
The company's cautious Q3 earnings guidance is worrying investors.
The orthodontic-device maker beat its expectations in the second quarter. But its third-quarter outlook was disappointing.
ALGN earnings call for the period ending June 30, 2019.
These three companies have recently fallen from grace, but is there a recovery on the horizon?